In this study, using a biomarker panel combining C2M, C-reactive protein metabolite (CRPM) and ADAMTS5 they could distinguish hemophilia patients from control subjects with 85.3% accuracy (p < 0.0001), unfortunately they found no strong correlation between biomarkers and radiological and physical examination of the joint [34]. This evidence concerns the gene CRP and hemophilia.